Where the evidence has converged — synthesized from landmark RCTs and meta-analyses across cardiology.
Does vericiguat vs placebo affect Heart Failure Hospitalization in Worsening Chronic Heart Failure with Reduced Ejection Fraction?
1 studies (5,050 patients, 1 RCTs) provide moderate-certainty evidence for benefit of vericiguat for Total heart-failure hospitalizations (first and recurrent) in Worsening Chronic Heart Failure with Reduced Ejection Fraction.
1 RCTs · 5,050 ptsDoes vericiguat vs placebo affect Cardiovascular Death or Heart Failure Hospitalization in Worsening Chronic Heart Failure with Reduced Ejection Fraction?
1 studies (5,050 patients, 1 RCTs) provide moderate-certainty evidence for benefit of vericiguat for Composite of cardiovascular death or first heart-failure hospitalization in Worsening Chronic Heart Failure with Reduced Ejection Fraction.
1 RCTs · 5,050 ptsDoes oral anticoagulation vs placebo improve All-Cause Mortality in Atrial Fibrillation?
20 studies (1,386,626 patients) provide low-certainty evidence for benefit of oral anticoagulation for All-Cause Mortality in Atrial Fibrillation.
1,386,626 ptsDoes bio-statin vs placebo improve outcomes in Graft failure?
6 studies (1,004,816 patients) provide low-certainty evidence for benefit of bio-statin for Left Ventricular Ejection Fraction in Graft failure.
1,004,816 ptsDoes apixaban vs warfarin improve outcomes in Atrial Fibrillation?
8 studies (97,866 patients) provide low-certainty evidence for benefit of apixaban for Stroke Hospitalization in Atrial Fibrillation.
97,866 ptsDoes exenatide vs placebo improve All-Cause Mortality in Diabetes Mellitus, Non-Insulin-Dependent?
5 studies (44,256 patients) provide low-certainty evidence for benefit of exenatide for All-Cause Mortality in Diabetes Mellitus, Non-Insulin-Dependent.
44,256 ptsDoes ticagrelor vs clopidogrel improve Myocardial Infarction Hospitalization in Acute Coronary Syndrome?
3 studies (41,464 patients) provide low-certainty evidence for benefit of ticagrelor for Myocardial Infarction Hospitalization in Acute Coronary Syndrome.
41,464 ptsDoes metformin vs placebo improve outcomes in Diabetes Mellitus, Non-Insulin-Dependent?
10 studies (33,024 patients) provide low-certainty evidence for benefit of metformin for Myocardial Infarction Hospitalization in Diabetes Mellitus, Non-Insulin-Dependent.
33,024 ptsDoes rivaroxaban vs warfarin improve Ventricular Arrhythmia in Nonvalvular atrial fibrillation?
3 studies (6,229 patients) provide low-certainty evidence for benefit of rivaroxaban for Ventricular Arrhythmia in Nonvalvular atrial fibrillation.
6,229 ptsDoes furosemide vs placebo improve outcomes in Severe tricuspid valve regurgitation?
10 studies (2,759 patients) provide low-certainty evidence for benefit of furosemide for Cardiac Output in Severe tricuspid valve regurgitation.
2,759 ptsDoes furosemide vs placebo improve Diastolic Blood Pressure in Pulmonary arterial hypertension?
2 studies (2,600 patients) provide low-certainty evidence for benefit of furosemide for Diastolic Blood Pressure in Pulmonary arterial hypertension.
2,600 ptsDoes direct-acting antiviral vs placebo improve outcomes in Hepatitis C?
4 studies (890 patients) provide low-certainty evidence for benefit of direct-acting antiviral for Cardiac Index in Hepatitis C.
890 ptsDoes antiplatelet vs placebo improve Cardiac Output in Percutaneous Coronary Intervention?
2 studies (472 patients) provide low-certainty evidence for benefit of antiplatelet for Cardiac Output in Percutaneous Coronary Intervention.
472 ptsDoes navitoclax vs placebo improve outcomes in cardiac ischemia-reperfusion injury?
2 studies (0 patients) provide low-certainty evidence for benefit of navitoclax for Myocardial Infarction Hospitalization in cardiac ischemia-reperfusion injury.
Does eplerenone vs placebo improve outcomes in Acute Inferior Myocardial Infarction?
2 studies (0 patients) provide low-certainty evidence for benefit of eplerenone for Myocardial Infarction Hospitalization in Acute Inferior Myocardial Infarction.
Does dabigatran vs warfarin improve outcomes in HEART-VALVE, MECHANICAL?
3 studies (0 patients) provide low-certainty evidence for benefit of dabigatran for Ventricular Arrhythmia in HEART-VALVE, MECHANICAL.
Does amiodarone vs nitrendipine improve outcomes?
3 studies (0 patients) provide low-certainty evidence for benefit of amiodarone for Myocardial Infarction Hospitalization in this population.
Does spironolactone vs placebo improve outcomes in Heart Failure?
21 studies (11,582 patients) provide insufficient evidence with mixed findings regarding spironolactone for Cardiac Output in Heart Failure.
11,582 ptsDoes pravastatin vs placebo improve outcomes in Dementia?
2 studies (10,584 patients) provide insufficient evidence with mixed findings regarding pravastatin for Ventricular Arrhythmia in Dementia.
10,584 ptsDoes pravastatin vs placebo improve Ventricular Arrhythmia in Dementia?
2 studies (10,584 patients) provide insufficient evidence with mixed findings regarding pravastatin for Ventricular Arrhythmia in Dementia.
10,584 ptsDoes pravastatin vs placebo improve Myocardial Infarction Hospitalization in Myocardial Infarction?
2 studies (8,318 patients) provide insufficient evidence with mixed findings regarding pravastatin for Myocardial Infarction Hospitalization in Myocardial Infarction.
8,318 ptsDoes furosemide vs placebo improve outcomes in Pulmonary arterial hypertension?
2 studies (2,600 patients) provide insufficient evidence with mixed findings regarding furosemide for Left Ventricular Ejection Fraction in Pulmonary arterial hypertension.
2,600 ptsDoes anakinra vs placebo improve outcomes in ST segment elevation myocardial infarction?
9 studies (792 patients) provide insufficient evidence with mixed findings regarding anakinra for Myocardial Infarction Hospitalization in ST segment elevation myocardial infarction.
792 ptsDoes trastuzumab vs placebo improve Cardiac Index in HER2-positive carcinoma of breast?
4 studies (572 patients) provide insufficient evidence with mixed findings regarding trastuzumab for Cardiac Index in HER2-positive carcinoma of breast.
572 ptsDoes ace inhibitors vs placebo improve outcomes in Heart failure?
2 studies (514 patients) provide insufficient evidence with mixed findings regarding ace inhibitors for Left Ventricular Ejection Fraction in Heart failure.
514 ptsDoes rivaroxaban vs placebo improve Cardiac Output in Congenital Heart Defects?
2 studies (250 patients) provide insufficient evidence with mixed findings regarding rivaroxaban for Cardiac Output in Congenital Heart Defects.
250 ptsDoes chemotherapy vs placebo improve Cardiac Output in Osteosarcoma?
3 studies (222 patients) provide insufficient evidence with mixed findings regarding chemotherapy for Cardiac Output in Osteosarcoma.
222 ptsDoes shr-1918 vs placebo improve outcomes in Healthy Volunteers?
2 studies (144 patients) provide insufficient evidence with mixed findings regarding shr-1918 for Serum Uric Acid in Healthy Volunteers.
144 ptsDoes chimeric antigen receptor t cells vs placebo improve outcomes in Myocardial fibrosis?
9 studies (106,960 patients) provide low-certainty evidence against benefit of chimeric antigen receptor t cells for Myocardial Infarction Hospitalization in Myocardial fibrosis.
106,960 ptsDoes amiodarone vs placebo improve outcomes in Atrial Fibrillation?
10 studies (49,075 patients) provide low-certainty evidence against benefit of amiodarone for Myocardial Infarction Hospitalization in Atrial Fibrillation.
49,075 ptsDoes statin vs placebo improve outcomes in Hypercholesterolemia, Familial?
12 studies (23,719 patients) provide low-certainty evidence against benefit of statin for Myocardial Infarction Hospitalization in Hypercholesterolemia, Familial.
23,719 ptsDoes insulin, regular, human vs placebo improve Urinary Tract Infection in Polypharmacy?
2 studies (10,710 patients) provide low-certainty evidence against benefit of insulin, regular, human for Urinary Tract Infection in Polypharmacy.
10,710 ptsDoes vericiguat vs placebo improve outcomes in Heart Failure, Systolic?
19 studies (8,689 patients) provide low-certainty evidence against benefit of vericiguat for Left Ventricular Ejection Fraction in Heart Failure, Systolic.
8,689 ptsDoes anticoagulation vs placebo improve outcomes in Pulmonary Embolism?
5 studies (6,343 patients) provide low-certainty evidence against benefit of anticoagulation for Cardiac Output in Pulmonary Embolism.
6,343 ptsDoes rivaroxaban vs apixaban improve outcomes?
10 studies (2,578 patients) provide low-certainty evidence against benefit of rivaroxaban for Cardiac Index in this population.
2,578 ptsDoes immune checkpoint inhibitors vs placebo improve outcomes in cancer therapy-related cardiovascular toxicity?
3 studies (324 patients) provide low-certainty evidence against benefit of immune checkpoint inhibitors for Cardiac Index in cancer therapy-related cardiovascular toxicity.
324 ptsDoes asparaginase vs placebo improve outcomes in L2 Acute Lymphoblastic Leukemia?
4 studies (221 patients) provide low-certainty evidence against benefit of asparaginase for Myocardial Infarction Hospitalization in L2 Acute Lymphoblastic Leukemia.
221 ptsDoes dapagliflozin vs placebo improve Left Ventricular Ejection Fraction in Heart Failure, Diastolic?
4 studies (148 patients) provide low-certainty evidence against benefit of dapagliflozin for Left Ventricular Ejection Fraction in Heart Failure, Diastolic.
148 ptsDoes clopidogrel vs placebo improve outcomes?
9 studies (80 patients) provide low-certainty evidence against benefit of clopidogrel for Major Adverse Cardiovascular Events in this population.
80 ptsDoes dipyridamole vs placebo improve Left Ventricular Ejection Fraction in Aortic Valve Stenosis?
2 studies (30 patients) provide low-certainty evidence against benefit of dipyridamole for Left Ventricular Ejection Fraction in Aortic Valve Stenosis.
30 ptsDoes oral antiplatelet agents vs placebo improve outcomes in Acute Coronary Syndrome?
3 studies (0 patients) provide low-certainty evidence against benefit of oral antiplatelet agents for Cardiac Output in Acute Coronary Syndrome.
Does ev71 vaccine vs placebo improve outcomes in human enterovirus 71 (ev71)?
3 studies (0 patients) provide low-certainty evidence against benefit of ev71 vaccine for Cardiac Output in human enterovirus 71 (ev71).
Does idarucizumab vs placebo improve outcomes in Disseminated Intravascular Coagulation?
Insufficient evidence (1 studies, 11561146 patients) to determine the effect of idarucizumab on Myocardial Infarction Hospitalization in Disseminated Intravascular Coagulation.
11,561,146 ptsDoes andexanet alfa vs placebo improve outcomes in Disseminated Intravascular Coagulation?
Insufficient evidence (1 studies, 11561146 patients) to determine the effect of andexanet alfa on Myocardial Infarction Hospitalization in Disseminated Intravascular Coagulation.
11,561,146 ptsDoes rivaroxaban vs apixaban improve outcomes in Venous Thromboembolism?
Insufficient evidence (1 studies, 298609 patients) to determine the effect of rivaroxaban on Cardiac Output in Venous Thromboembolism.
298,609 ptsDoes anakinra vs placebo improve Myocardial Infarction Hospitalization in Diabetes Mellitus, Non-Insulin-Dependent?
Insufficient evidence (1 studies, 60081 patients) to determine the effect of anakinra on Myocardial Infarction Hospitalization in Diabetes Mellitus, Non-Insulin-Dependent.
60,081 ptsDoes doac vs aspirin improve Major Bleeding in left atrial appendage occlusion?
Insufficient evidence (1 studies, 53878 patients) to determine the effect of doac on Major Bleeding in left atrial appendage occlusion.
53,878 ptsDoes sirolimus vs sirolimus improve outcomes in Incomplete stent apposition?
Insufficient evidence (1 studies, 34120 patients) to determine the effect of sirolimus on Cardiac Output in Incomplete stent apposition.
34,120 ptsDoes socioeconomic deprivation (per imd decile increase) vs placebo improve All-Cause Mortality in Mitral Valve Insufficiency?
Insufficient evidence (1 studies, 6665 patients) to determine the effect of socioeconomic deprivation (per imd decile increase) on All-Cause Mortality in Mitral Valve Insufficiency.
6,665 ptsDoes ambulatory hypertension vs placebo improve Left Ventricular Mass Index in Renal Insufficiency, Chronic?
Insufficient evidence (1 studies, 6509 patients) to determine the effect of ambulatory hypertension on Left Ventricular Mass Index in Renal Insufficiency, Chronic.
6,509 ptsDoes dexmedetomidine vs placebo improve outcomes in Hypertensive disease?
Insufficient evidence (1 studies, 5769 patients) to determine the effect of dexmedetomidine on Acute Kidney Injury in Hypertensive disease.
5,769 ptsDoes proton-pump inhibitors vs placebo improve Cardiac Output in Acute Coronary Syndrome?
Insufficient evidence (1 studies, 4595 patients) to determine the effect of proton-pump inhibitors on Cardiac Output in Acute Coronary Syndrome.
4,595 ptsDoes percutaneous closure of iatrogenic atrial septal defect (pc-asd) vs placebo improve Stroke Hospitalization in iatrogenic atrial septal defect?
Insufficient evidence (1 studies, 4440 patients) to determine the effect of percutaneous closure of iatrogenic atrial septal defect (pc-asd) on Stroke Hospitalization in iatrogenic atrial septal defect.
4,440 ptsDoes clopidogrel vs aspirin improve outcomes in Cardiac Death?
Insufficient evidence (1 studies, 3243 patients) to determine the effect of clopidogrel on Cardiovascular Mortality in Cardiac Death.
3,243 ptsDoes clopidogrel vs aspirin improve Cardiovascular Mortality in Cardiac Death?
Insufficient evidence (1 studies, 3243 patients) to determine the effect of clopidogrel on Cardiovascular Mortality in Cardiac Death.
3,243 ptsDoes tavr vs placebo improve Major Bleeding in Aortic Valve Stenosis?
Insufficient evidence (1 studies, 2082 patients) to determine the effect of tavr on Major Bleeding in Aortic Valve Stenosis.
2,082 ptsDoes fibrinolysis inhibitor vs placebo improve outcomes in Heart Failure, Systolic?
Insufficient evidence (1 studies, 2045 patients) to determine the effect of fibrinolysis inhibitor on Left Ventricular Ejection Fraction in Heart Failure, Systolic.
2,045 ptsDoes beta-blockers vs fibrinolysis inhibitor improve outcomes in Heart Failure, Systolic?
Insufficient evidence (1 studies, 2045 patients) to determine the effect of beta-blockers on Left Ventricular Ejection Fraction in Heart Failure, Systolic.
2,045 ptsDoes antioxidant vitamins vs placebo improve Myocardial Infarction Hospitalization in Cardiac surgery specialty?
Insufficient evidence (1 studies, 1584 patients) to determine the effect of antioxidant vitamins on Myocardial Infarction Hospitalization in Cardiac surgery specialty.
1,584 ptsDoes trastuzumab vs methacycline improve outcomes in cancer therapy-related cardiac dysfunction?
Insufficient evidence (1 studies, 1440 patients) to determine the effect of trastuzumab on Cardiac Output in cancer therapy-related cardiac dysfunction.
1,440 ptsDoes beta blockers vs placebo improve outcomes in Cardiomyopathy, Hypertrophic?
Insufficient evidence (1 studies, 590 patients) to determine the effect of beta blockers on Myopathy / Rhabdomyolysis in Cardiomyopathy, Hypertrophic.
590 ptsDoes ketamine vs xylazine improve Myocardial Infarction Hospitalization in Heart failure?
Insufficient evidence (1 studies, 502 patients) to determine the effect of ketamine on Myocardial Infarction Hospitalization in Heart failure.
502 ptsDoes beta-blockers vs renin-angiotensin system inhibitors improve Myocardial Infarction Hospitalization in secondary mitral regurgitation?
Insufficient evidence (1 studies, 463 patients) to determine the effect of beta-blockers on Myocardial Infarction Hospitalization in secondary mitral regurgitation.
463 ptsDoes lmna mutation vs placebo improve Left Ventricular Reverse Remodeling in Cardiomyopathy, Dilated?
Insufficient evidence (1 studies, 346 patients) to determine the effect of lmna mutation on Left Ventricular Reverse Remodeling in Cardiomyopathy, Dilated.
346 ptsDoes high bleeding risk (hbr) vs placebo improve Stroke Hospitalization in calcified coronary artery disease?
Insufficient evidence (1 studies, 343 patients) to determine the effect of high bleeding risk (hbr) on Stroke Hospitalization in calcified coronary artery disease.
343 ptsDoes guideline-directed medical therapy vs placebo improve Myocardial Infarction Hospitalization in secondary mitral regurgitation?
Insufficient evidence (1 studies, 261 patients) to determine the effect of guideline-directed medical therapy on Myocardial Infarction Hospitalization in secondary mitral regurgitation.
261 ptsDoes renin-angiotensin system inhibitor vs mineralocorticoid receptor antagonist improve outcomes in Heart Failure, Systolic?
Insufficient evidence (1 studies, 257 patients) to determine the effect of renin-angiotensin system inhibitor on Left Ventricular Ejection Fraction in Heart Failure, Systolic.
257 ptsDoes allopurinol vs placebo improve outcomes in Heart failure?
Insufficient evidence (1 studies, 253 patients) to determine the effect of allopurinol on Myocardial Infarction Hospitalization in Heart failure.
253 ptsDoes liraglutide vs placebo improve Left Ventricular Ejection Fraction in Chronic heart failure?
Insufficient evidence (1 studies, 241 patients) to determine the effect of liraglutide on Left Ventricular Ejection Fraction in Chronic heart failure.
241 ptsDoes mean nighttime sbp per 10-mmhg increase vs placebo improve Heart failure rehospitalization in Heart Failure, Systolic?
Insufficient evidence (1 studies, 235 patients) to determine the effect of mean nighttime sbp per 10-mmhg increase on Heart failure rehospitalization in Heart Failure, Systolic.
235 ptsDoes eras protocol adherence ≥70% vs placebo improve All-Cause Mortality in open aortic surgery?
Insufficient evidence (1 studies, 206 patients) to determine the effect of eras protocol adherence ≥70% on All-Cause Mortality in open aortic surgery.
206 ptsDoes geminione teer system vs placebo improve NYHA Functional Class in degenerative mitral regurgitation?
Insufficient evidence (1 studies, 120 patients) to determine the effect of geminione teer system on NYHA Functional Class in degenerative mitral regurgitation.
120 ptsDoes enoxaparin vs placebo improve outcomes in ST segment elevation myocardial infarction?
Insufficient evidence (1 studies, 102 patients) to determine the effect of enoxaparin on Myocardial Infarction Hospitalization in ST segment elevation myocardial infarction.
102 ptsDoes opioid vs placebo improve outcomes in Total Hip Replacement?
Insufficient evidence (1 studies, 88 patients) to determine the effect of opioid on Cardiac Output in Total Hip Replacement.
88 ptsDoes 11c-acetate vs placebo improve Cardiac Output in AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED?
Insufficient evidence (1 studies, 48 patients) to determine the effect of 11c-acetate on Cardiac Output in AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED.
48 ptsDoes dapagliflozin vs placebo improve outcomes in Heart Failure, Diastolic?
Insufficient evidence (1 studies, 37 patients) to determine the effect of dapagliflozin on Left Ventricular Ejection Fraction in Heart Failure, Diastolic.
37 ptsDoes vitamin d vs placebo improve outcomes in Morbid obesity?
Insufficient evidence (1 studies, 32 patients) to determine the effect of vitamin d on Myocardial Infarction Hospitalization in Morbid obesity.
32 ptsDoes apixaban vs placebo improve Major Bleeding in Congenital Heart Defects?
Insufficient evidence (1 studies, 30 patients) to determine the effect of apixaban on Major Bleeding in Congenital Heart Defects.
30 ptsDoes liraglutide vs metformin improve Cardiac Output in Diabetes Mellitus, Type 2?
Insufficient evidence (1 studies, 27 patients) to determine the effect of liraglutide on Cardiac Output in Diabetes Mellitus, Type 2.
27 ptsDoes mineralocorticoid receptor antagonists vs placebo improve Cardiac Output in Conn Syndrome?
Insufficient evidence (1 studies, 21 patients) to determine the effect of mineralocorticoid receptor antagonists on Cardiac Output in Conn Syndrome.
21 ptsDoes total ev secreted by ipsc-pg vs placebo improve Left Ventricular End-Systolic Volume in Myocardial Infarction?
Insufficient evidence (1 studies, 19 patients) to determine the effect of total ev secreted by ipsc-pg on Left Ventricular End-Systolic Volume in Myocardial Infarction.
19 ptsDoes mrna-based covid-19 vaccine vs placebo improve C-Reactive Protein in Myocarditis?
Insufficient evidence (1 studies, 16 patients) to determine the effect of mrna-based covid-19 vaccine on C-Reactive Protein in Myocarditis.
16 ptsDoes aspirin vs ticlopidine improve outcomes?
Insufficient evidence (1 studies, 10 patients) to determine the effect of aspirin on Cardiac Output in this population.
10 ptsDoes sildenafil vs fluorodeoxyglucose f18 improve outcomes in Hypertension, Pulmonary?
Insufficient evidence (1 studies, 9 patients) to determine the effect of sildenafil on Left Ventricular Ejection Fraction in Hypertension, Pulmonary.
9 ptsDoes surgical intervention and standard heart failure therapy vs placebo improve Left Ventricular Ejection Fraction in Peripartum cardiomyopathy?
Insufficient evidence (1 studies, 1 patients) to determine the effect of surgical intervention and standard heart failure therapy on Left Ventricular Ejection Fraction in Peripartum cardiomyopathy.
1 ptsDoes zodasiran vs solbinsiran improve LDL Cholesterol Change in mixed dyslipidemia?
Does yk-4-250 vs tempol improve All-Cause Mortality in acute gastrointestinal radiation syndrome?
Does xaf-1407 vs placebo improve QT Prolongation in Atrial Fibrillation?
Does warfarin vs sulfonylureas improve Hypoglycemia in Hypoglycemia?
Does warfarin vs placebo improve Quality-Adjusted Life Years in Nonvalvular atrial fibrillation?
Does warfarin vs placebo improve Major Bleeding in Thromboembolism?
Does warfarin vs placebo improve All-Cause Mortality in Malignant Neoplasms?
Does warfarin vs placebo improve All-Cause Mortality in Atrial Fibrillation?
Does warfarin vs placebo improve All-Cause Hospitalization in Atrial Fibrillation?
Does warfarin vs doans improve All-Cause Mortality in Cardiomyopathy, Dilated?
Does warfarin vs dabigatran improve Stroke Hospitalization in non-valvular atrial fibrillation?
Does warfarin vs dabigatran improve Estimated Glomerular Filtration Rate in Atrial Fibrillation?
Does warfarin vs aspirin improve Major Bleeding in Major bleeding - TIMI classification?
Does warfarin vs apixaban improve All-Cause Mortality in Atrial Fibrillation?
Does vitamin k antagonist vs placebo improve Intracranial Hemorrhage in Atrial Fibrillation?
Does vitamin k antagonist vs non-vitamin k antagonist oral anticoagulant improve Intracranial Hemorrhage in non-valvular atrial fibrillation?
Does vitamin k antagonist vs antiplatelet improve outcomes in Thromboembolism?
Insufficient evidence (1 studies, 0 patients) to determine the effect of vitamin k antagonist on Myocardial Infarction Hospitalization in Thromboembolism.
Does valsartan vs ace inhibitors improve outcomes in Heart failure?
Insufficient evidence (1 studies, 0 patients) to determine the effect of valsartan on C-Reactive Protein in Heart failure.
Does valsartan vs ace inhibitor improve outcomes in Chronic heart failure?
Insufficient evidence (1 studies, 0 patients) to determine the effect of valsartan on Left Ventricular Ejection Fraction in Chronic heart failure.
Does urokinase vs placebo improve Left Ventricular Ejection Fraction in Acute ST segment elevation myocardial infarction (disorder)?
Does urate-lowering therapy vs placebo improve Stroke (Safety Event) in Atrial Fibrillation?
Does trimetazidine vs placebo improve Left Ventricular End-Systolic Volume in Cardiomyopathies?
Does triheptanoin vs triheptanoin improve Left Ventricular Ejection Fraction in long-chain fatty acid oxidation disorders?
Does treprostinil vs placebo improve Six-Minute Walk Test Distance in Pulmonary arterial hypertension?
Does trastuzumab vs perindopril improve Global Longitudinal Strain in Malignant neoplasm of breast?
Does trastuzumab vs bisoprolol improve Global Longitudinal Strain in Malignant neoplasm of breast?
Does torsemide vs placebo improve Body Weight Change in Heart failure?
Does tirzepatide vs placebo improve Body Weight Change in Diabetes Mellitus, Non-Insulin-Dependent?
Does tirofiban vs placebo improve Intracranial Hemorrhage in Acute Ischemic Stroke?
Does ticagrelor vs placebo improve Myocardial Infarction Hospitalization in Acute Coronary Syndrome?
Does ticagrelor vs placebo improve Major Adverse Cardiovascular Events in Non-ST Elevated Myocardial Infarction?
Does ticagrelor vs placebo improve Left Ventricular Ejection Fraction in Myocardial Infarction?
Does ticagrelor vs placebo improve Cardiovascular Mortality in Diabetes Mellitus?
Does ticagrelor vs clopidogrel improve Major Bleeding in Percutaneous Coronary Intervention?
Does ticagrelor vs clopidogrel improve Bradycardia in Acute Coronary Syndrome?
Does ticagrelor vs aspirin improve Stroke Hospitalization in Coronary Artery Bypass Surgery?
Does ticagrelor vs aspirin improve Myocardial Infarction Hospitalization in Coronary Artery Disease?
Does ticagrelor vs aspirin improve Intracranial Hemorrhage in stable coronary artery disease?
Does ticagrelor vs aspirin improve Cardiac Index in PCI 24781?
Insufficient evidence (1 studies, 0 patients) to determine the effect of ticagrelor on Cardiac Index in PCI 24781.
Does thrombolysis vs anticoagulant improve All-Cause Mortality in acute symptomatic pulmonary embolism?
Does thiamine vs digoxin improve Cardiac Index in Advanced Heart Failure and Transplant Internist?
Does teneligliptin vs sulfonylurea improve Stroke Hospitalization in Diabetes Mellitus, Non-Insulin-Dependent?
Does tenecteplase vs placebo improve Major Adverse Cardiovascular Events in ST segment elevation myocardial infarction?
Does telmisartan vs placebo improve Stroke Hospitalization in Hypertensive disease?
Does telmisartan vs calcium channel blocker improve Atrial Fibrillation Recurrence in Atrial Fibrillation?
Does technetium 99m vs placebo improve Left Ventricular Ejection Fraction in Coronary Artery Disease?
Does surpass anti-inflammatory vs oral anticoagulants improve Stroke Hospitalization in Stroke?
Does sulodexide vs placebo improve Stroke Hospitalization in Myocardial Infarction?
Does sulfonylureas vs placebo improve Myocardial Infarction Hospitalization in Diabetes Mellitus, Type 2?
Does sufentanil vs medetomidine improve Ventricular Fibrillation in Myocardial Infarction?
Does streptozocin vs placebo improve Heart Rate in Diabetic Cardiomyopathies?
Does streptokinase vs placebo improve Ventricular Arrhythmia in acute st elevation myocardial infarction?
Does statin vs placebo improve Stroke Hospitalization in Cardiovascular Diseases?
Does statin vs placebo improve Major Adverse Cardiovascular Events in Cardiovascular Diseases?
Does statin vs placebo improve Cardiovascular Mortality?
Does statin vs placebo improve All-Cause Mortality in Peripheral Arterial Diseases?
Does statin vs placebo improve All-Cause Mortality in Ischemic stroke?
Does statin vs lisinopril improve outcomes in Hypertensive disease?
Insufficient evidence (1 studies, 0 patients) to determine the effect of statin on Ventricular Arrhythmia in Hypertensive disease.
Does statin vs immune checkpoint inhibitors improve All-Cause Mortality in Malignant neoplasm of lung?
Does statin vs beta-blocker improve All-Cause Mortality in Acute Inferior Myocardial Infarction?
Does ssris vs anticoagulants improve Major Bleeding in Major bleeding - TIMI classification?
Does ssri vs placebo improve All-Cause Mortality?
Does spironolactone vs placebo improve Serum Creatinine in Hypertension Resistant to Conventional Therapy?
Does spironolactone vs placebo improve Heart Failure Hospitalization in Heart Failure, Diastolic?
Does spironolactone vs placebo improve Estimated Glomerular Filtration Rate in ADHF?
Does sotalol vs placebo improve Atrial Fibrillation Recurrence in Atrial Fibrillation?
Does sotalol vs amiodarone improve Atrial Fibrillation Recurrence in Atrial Fibrillation?
Does sodium-glucose cotransporter-2 inhibitors vs thiazolidinedione improve Stroke Hospitalization in Diabetes Mellitus, Non-Insulin-Dependent?
Does sodium-glucose co-transporter 2 inhibitors vs placebo improve Atrial Fibrillation Recurrence in Atrial Fibrillation?
Does sitagliptin vs sulfonylureas improve Heart Failure Hospitalization in Diabetes Mellitus, Non-Insulin-Dependent?
Does sirolimus vs zotarolimus improve outcomes in Chronic total occlusion of coronary artery?
Insufficient evidence (1 studies, 0 patients) to determine the effect of sirolimus on Cardiac Output in Chronic total occlusion of coronary artery.
Does sirolimus vs sirolimus improve Major Adverse Cardiovascular Events in Cardiology (cardiovascular disease), analysis of 4 proteins (NT-proBNP, osteopontin, tissue inhibitor of metalloproteinase-1 [TIMP-1], and kidney injury molecule-1 [KIM-1]), plasma, algorithm reported as a risk score for major adverse cardiac event?
Does sildenafil vs placebo improve Pulmonary Capillary Wedge Pressure in swimming-induced pulmonary edema?
Does sildenafil vs placebo improve Heart Rate in Diabetes Mellitus?
Does sglt2i vs placebo improve Cardiovascular Mortality in Heart Failure, Diastolic?
Does sglt2 inhibitors vs placebo improve outcomes in Cardiovascular Diseases?
Insufficient evidence (1 studies, 0 patients) to determine the effect of sglt2 inhibitors on Ventricular Arrhythmia in Cardiovascular Diseases.
Does sglt2 inhibitors vs placebo improve Stroke (Safety Event) in Diabetes Mellitus, Non-Insulin-Dependent?
Does sglt2 inhibitors vs placebo improve NT-proBNP in ADHF?
Does sglt2 inhibitors vs placebo improve Major Adverse Cardiovascular Events in Diabetes Mellitus, Non-Insulin-Dependent?
Does sglt2 inhibitors vs placebo improve Left Ventricular Reverse Remodeling in Heart failure?
Does sglt2 inhibitors vs placebo improve Heart Failure Hospitalization in Heart failure?
Does sglt2 inhibitors vs placebo improve Glycated Hemoglobin in Diabetes Mellitus, Type 2?
Does sglt2 inhibitors vs placebo improve Cardiovascular Mortality in Heart failure?
Does sglt2 inhibitors vs placebo improve All-Cause Mortality in Atrioventricular Block?
Does sglt2 inhibitors vs empagliflozin improve Diuretic Response / Efficiency in Heart failure?
Does sglt2 inhibitors vs dpp4 inhibitors improve New-Onset Atrial Fibrillation in Diabetes Mellitus, Non-Insulin-Dependent?
Does sglt2 inhibitors vs dpp-4 inhibitors improve All-Cause Hospitalization in Diabetes Mellitus, Type 2?
Does sglt2 inhibitor vs placebo improve Glycated Hemoglobin in Diabetes Mellitus, Non-Insulin-Dependent?
Does sglt-2i vs anakinra improve New-Onset Atrial Fibrillation in Diabetes Mellitus, Type 2?
Does severe tricuspid regurgitation vs placebo improve All-Cause Mortality in Tricuspid Valve Insufficiency?
Does semaglutide vs placebo improve CV Death, HF Hospitalization, or Urgent HF Visit in Heart Failure, Diastolic?
Does semaglutide vs placebo improve Body Weight Change in Obesity?
Does selective serotonin reuptake inhibitors vs placebo improve Stroke Hospitalization in Mental Depression?
Does saxagliptin vs placebo improve Myocardial Infarction Hospitalization in Diabetes Mellitus, Type 2?
Does sacubitril / valsartan vs valsartan improve NT-proBNP in Heart failure?
Does sacubitril / valsartan vs placebo improve Worsening Renal Function in Renal Insufficiency, Chronic?
Does sacubitril / valsartan vs placebo improve Systolic Blood Pressure in Renal Insufficiency, Chronic?
Does sacubitril / valsartan vs placebo improve Sudden Cardiac Death in Chronic heart failure?
Does sacubitril / valsartan vs placebo improve NT-proBNP in Heart Failure, Systolic?
Does sacubitril / valsartan vs placebo improve Left Ventricular Ejection Fraction in Acute Inferior Myocardial Infarction?
Does sacubitril / valsartan vs enalapril improve Heart Failure Hospitalization in Heart Failure, Systolic?
Does sacubitril / valsartan vs enalapril improve Cardiovascular Death or Heart Failure Hospitalization in Heart Failure, Systolic?
Does sacubitril / valsartan vs enalapril improve CV Death, HF Hospitalization, or Urgent HF Visit in Heart failure?
Does sacubitril / valsartan vs benazepril improve Left Ventricular End-Systolic Volume in ST Elevation Myocardial Infarction?
Does sacubitril / valsartan vs angiotensin-converting enzyme inhibitors improve All-Cause Mortality in Heart Failure, Systolic?
Does sacubitril / valsartan vs acei improve Symptomatic Hypotension in Heart failure?
Does sacubitril / valsartan vs ace inhibitor improve All-Cause Hospitalization in Heart Failure, Systolic?
Does roxadustat vs placebo improve All-Cause Mortality in Renal Insufficiency, Chronic?
Does rosuvastatin vs placebo improve All-Cause Mortality in All-Cause Mortality?
Does rivaroxaban vs warfarin improve Stroke (Safety Event) in Atrial Fibrillation?
Does rivaroxaban vs warfarin improve Major Bleeding in Pulmonary Embolism?
Does rivaroxaban vs warfarin improve All-Cause Mortality in Nonvalvular atrial fibrillation?
Does rivaroxaban vs placebo improve Major Bleeding in Atrial Fibrillation?
Does rivaroxaban vs placebo improve Cardiovascular Mortality in non-valvular atrial fibrillation?
Does rivaroxaban vs low molecular weight heparin improve All-Cause Mortality in Cancer-associated thrombosis?
Create a free account to filter by intervention × outcome, follow individual questions, and get notified as new RCTs change the picture.